AKBA CIK: 1517022

Akebia Therapeutics, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY22
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
billions USD
FY22:
0.24
FY22:
0.19
FY23:
0.12
FY24:
0.11
FY25:
0.25
(positive)
Change from FY22 to FY25
billions USD
FY22:
0.20
FY22:
0.17
FY23:
0.12
FY24:
0.11
FY25:
0.12
Total assets
Change from FY22 to FY25
billions USD
FY22:
0.44
FY22:
0.36
FY23:
0.24
FY24:
0.22
FY25:
0.38

Liabilities & Equity

(negative)
Change from FY22 to FY25
billions USD
FY22:
0.19
FY22:
0.13
FY23:
0.10
FY24:
0.08
FY25:
0.16
(negative)
Change from FY22 to FY25
billions USD
FY22:
0.24
FY22:
0.22
FY23:
0.17
FY24:
0.19
FY25:
0.18
(positive)
Change from FY22 to FY25
billions USD
FY22:
–
FY22:
0.01
FY23:
−0.03
FY24:
−0.05
FY25:
0.03
Total liabilities & equity
Change from FY22 to FY25
billions USD
FY22:
–
FY22:
0.36
FY23:
0.24
FY24:
0.22
FY25:
0.38

All amounts in billions USD Data source:SEC EDGAR